These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2293 related items for PubMed ID: 11695224

  • 1. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ, Craig Jordan V.
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen in ductal carcinoma in situ.
    Daly MB.
    Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
    Breast Cancer Res; 2008 Dec; 10(5):R88. PubMed ID: 18928543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M, Moro C, Ferretti G, Calabro MG, Nolè F, Rocca A, Munzone E, Castro A, Curigliano G.
    Anticancer Res; 2001 Dec; 21(1B):585-8. PubMed ID: 11299809
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 11. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Mar 02; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 12. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y, Kurosumi M, Kobayashi Y, Tanuma J, Suemasu K, Higashi Y, Kasamatsu T, Shiromizu K, Matsuzawa M, Kishi K.
    Anticancer Res; 1996 Mar 02; 16(5A):2993-6. PubMed ID: 8917418
    [Abstract] [Full Text] [Related]

  • 13. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F.
    Cancer; 1998 May 01; 82(9):1698-703. PubMed ID: 9576291
    [Abstract] [Full Text] [Related]

  • 17. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
    Cataliotti L, Buzdar AU, Noguchi S, Bines J, Takatsuka Y, Petrakova K, Dube P, de Oliveira CT.
    Cancer; 2006 May 15; 106(10):2095-103. PubMed ID: 16598749
    [Abstract] [Full Text] [Related]

  • 18. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR.
    Clin Cancer Res; 2001 Dec 15; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [Abstract] [Full Text] [Related]

  • 19. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI.
    Cancer Treat Res; 1998 Dec 15; 94():158-80. PubMed ID: 9587687
    [No Abstract] [Full Text] [Related]

  • 20. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG, Costantino JP, Wickerham DL, Cronin WM.
    Clin Cancer Res; 2003 Jan 15; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 115.